查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1862181

畜牧疫苗：全球市場佔有率和排名、總收入和需求預測（2025-2031 年）

Livestock Animal Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球牲畜疫苗市場規模估計為 57.66 億美元，預計到 2031 年將達到 85.96 億美元，在預測期（2025-2031 年）內複合年成長率為 5.9%。

本報告對近期關稅調整和國際戰略反制措施，涉及畜牧疫苗的跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組，進行了全面評估。

畜禽疫苗是用來預防和控制牲畜及其他經濟動物感染疾病的生物製藥。它們透過誘導特異性免疫反應，降低疾病發生率和死亡率，從而保障畜產品安全和食品供應鏈的穩定性。該類疫苗包括去活化疫苗、減毒活病毒疫苗、重組疫苗和次單位疫苗疫苗，可有效預防多種病原體，包括病毒、細菌和寄生蟲。畜禽疫苗產業是全球動物健康和生物安全體系的基礎，廣泛應用於牛、豬、羊和家禽養殖。隨著疾病防治政策日益嚴格、畜牧業的化和規模化的加速發展以及生物技術的不斷進步，畜禽疫苗已成為現代畜牧業和公共衛生體系的重要策略組成部分。 2024年，全球畜禽疫苗產量預計將達到約4,300億劑，全球平均市場價格約為每公斤13.4美元。

全球畜牧疫苗市場的發展主要受畜牧業工業化生產和大規模農業加速發展的推動，疾病預防和動物健康管理已成為關鍵的競爭優勢。疫苗技術的快速創新，尤其是在mRNA、重組蛋白和奈米顆粒遞送平台方面的創新，使得疫苗研發更加精準、高效和可追溯。政府對農業和動物健康政策的投入，以及對食品安全和公共衛生日益成長的關注，進一步擴大了疫苗的普及應用。跨國動物健康巨頭和區域領導者正在加大研發投入，以提供涵蓋多種疾病和物種的多元化疫苗組合。市場正朝著優質化、專業化和全球化方向發展。儘管成長前景強勁，但該行業仍面臨諸多挑戰，包括高昂的研發成本、漫長的監管核准流程以及複雜的國際貿易政策。動物病原體的多樣性和快速變異要求疫苗的研發和檢驗必須及時且科學嚴謹。低溫運輸基礎設施和儲存要求增加了營運成本，尤其是在新興市場。同時，該產業也面臨突發性區域疾病爆發、貿易壁壘和激烈的價格競爭等挑戰，這些都威脅盈利。企業必須持續投資於創新、智慧財產權保護和供應鏈最佳化，以維持市場韌性和產品競爭力。畜牧疫苗的需求正從傳統的疾病預防轉向高價值的精準健康管理解決方案。農民和動物健康組織正在引入聯合疫苗和客製化免疫方案，以提高生產力和動物福利。意識提升，正在推動源頭的無病生產，並加速優質疫苗和創新免疫技術的應用。數位化農場管理和精密農業解決方案正在推動疫苗市場與智慧農業和物聯網平台之間的深度合作。

畜牧疫苗的生產高度依賴高品質的種子菌株、細胞株、培養基和佐劑系統，所有這些都受到嚴格的監管標準和重大的技術障礙的限制。全球上游市場高度集中，關鍵組件由少數幾家跨國供應商和專業生物技術公司控制。生物發酵、無血清培養和奈米技術的進步使得某些原料的在地採購成為可能，提高了疫苗生產商的靈活性。然而，動物性原料的可追溯性、品質一致性和國際認證仍然是該產業面臨的主要挑戰，因此供應鏈安全是策略規劃的核心要素。

本報告旨在按地區/國家、類型和應用對全球畜牧疫苗市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以銷售量（百萬劑）和收入（百萬美元）為單位，對畜牧疫苗市場規模、估值和預測進行了呈現，基準年為2024年，並涵蓋了2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定畜牧疫苗業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Merck
  • Boehringer Ingelheim
  • Zoetis
  • Ceva
  • Elanco
  • CAHIC
  • Jinyu Bio-Technology
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • Kyoto Biken Laboratories
  • WINSUN
  • FATRO
  • CAVAC
  • MEVAC
  • Biovac
  • Cavet bio
  • Vaksindo
  • Bio-Labs

按類型分類的細分市場

  • 活病毒疫苗
  • 去活化疫苗
  • 其他疫苗

應用領域

  • 豬
  • 牛
  • 家禽
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Livestock Animal Vaccines was estimated to be worth US$ 5766 million in 2024 and is forecast to a readjusted size of US$ 8596 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Livestock Animal Vaccines cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Livestock animal vaccines are biological products designed to prevent and control infectious diseases in livestock and other economically important animals. By inducing specific immune responses, they help reduce disease incidence and mortality, ensuring the safety of livestock production and the stability of the food supply chain. This category includes inactivated, live-attenuated, recombinant, and subunit vaccines, offering protection against a wide range of pathogens, including viruses, bacteria, and parasites. The livestock animal vaccine industry serves as a cornerstone of the global animal health and biosecurity system, widely applied in cattle, swine, sheep, and poultry farming. With increasingly stringent disease prevention policies, accelerating livestock industrialization and scaling, and continuous advancements in biotechnology, livestock animal vaccines have become an indispensable strategic component of modern animal husbandry and public health systems.In 2024, global livestock animal vaccines production reached approximately 430 billion units , with an average global market price of around US$ 13.4 per k dose.

The global livestock animal vaccines market is driven by accelerating livestock industrialization and large-scale farming, making disease prevention and animal health management key competitive advantages. Rapid innovation in vaccine technology, particularly mRNA, recombinant protein, and nanoparticle delivery platforms, is enabling more precise, efficient, and traceable vaccine development. Governmental investment in agriculture and animal health policies, combined with heightened focus on food safety and public health, has further expanded vaccine adoption. Multinational animal health leaders and regional champions are intensifying R&D efforts, offering diversified vaccine portfolios covering multiple diseases and species, while the market evolves toward premiumization, specialization, and globalization.Despite its strong growth prospects, the industry faces multiple hurdles, including high R&D costs, lengthy regulatory approval processes, and complex global trade policies. The diversity and rapid mutation of animal pathogens demand timely and scientifically rigorous vaccine development and validation. Cold-chain infrastructure and storage requirements increase operational costs, particularly in emerging markets. Meanwhile, sudden regional disease outbreaks, trade barriers, and intense price competition challenge profitability. Companies must continuously invest in innovation, intellectual property protection, and supply chain optimization to maintain market resilience and product competitiveness.Demand for livestock animal vaccines is shifting from traditional disease prevention to high-value, precision health management solutions. Livestock producers and animal health organizations are adopting combination vaccines and customized immunization programs to enhance productivity and animal welfare. Rising consumer awareness of food safety and animal welfare is driving the industry toward disease-free production at the source, accelerating adoption of premium vaccines and innovative immunization technologies. Digital farm management and precision farming solutions are fostering deeper integration between the vaccine market and smart agriculture or IoT-enabled platforms.

Livestock animal vaccine production relies heavily on high-quality seed strains, cell lines, culture media, and adjuvant systems, all of which involve stringent regulatory standards and high technological barriers. The global upstream market is highly concentrated, with key components controlled by a small number of multinational suppliers and biotech specialists. Advances in biofermentation, serum-free culture, and nanotechnology have enabled localized sourcing of certain raw materials, offering more flexibility to vaccine manufacturers. However, traceability, quality consistency, and international certification of animal-derived raw materials remain top industry concerns, making supply chain security a core component of strategic planning.

This report aims to provide a comprehensive presentation of the global market for Livestock Animal Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Livestock Animal Vaccines by region & country, by Type, and by Application.

The Livestock Animal Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Dose) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Livestock Animal Vaccines.

Market Segmentation

By Company

  • Merck
  • Boehringer Ingelheim
  • Zoetis
  • Ceva
  • Elanco
  • CAHIC
  • Jinyu Bio-Technology
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • Kyoto Biken Laboratories
  • WINSUN
  • FATRO
  • CAVAC
  • MEVAC
  • Biovac
  • Cavet bio
  • Vaksindo
  • Bio-Labs

Segment by Type

  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Other Vaccines

Segment by Application

  • Pig
  • Cattle
  • Poultry
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Livestock Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Livestock Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Livestock Animal Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Livestock Animal Vaccines Product Introduction
  • 1.2 Global Livestock Animal Vaccines Market Size Forecast
    • 1.2.1 Global Livestock Animal Vaccines Sales Value (2020-2031)
    • 1.2.2 Global Livestock Animal Vaccines Sales Volume (2020-2031)
    • 1.2.3 Global Livestock Animal Vaccines Sales Price (2020-2031)
  • 1.3 Livestock Animal Vaccines Market Trends & Drivers
    • 1.3.1 Livestock Animal Vaccines Industry Trends
    • 1.3.2 Livestock Animal Vaccines Market Drivers & Opportunity
    • 1.3.3 Livestock Animal Vaccines Market Challenges
    • 1.3.4 Livestock Animal Vaccines Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Livestock Animal Vaccines Players Revenue Ranking (2024)
  • 2.2 Global Livestock Animal Vaccines Revenue by Company (2020-2025)
  • 2.3 Global Livestock Animal Vaccines Players Sales Volume Ranking (2024)
  • 2.4 Global Livestock Animal Vaccines Sales Volume by Company Players (2020-2025)
  • 2.5 Global Livestock Animal Vaccines Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Livestock Animal Vaccines Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Livestock Animal Vaccines Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Livestock Animal Vaccines
  • 2.9 Livestock Animal Vaccines Market Competitive Analysis
    • 2.9.1 Livestock Animal Vaccines Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Livestock Animal Vaccines Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Livestock Animal Vaccines as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Live Attenuated Vaccine
    • 3.1.2 Inactivated Vaccine
    • 3.1.3 Other Vaccines
  • 3.2 Global Livestock Animal Vaccines Sales Value by Type
    • 3.2.1 Global Livestock Animal Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Livestock Animal Vaccines Sales Value, by Type (2020-2031)
    • 3.2.3 Global Livestock Animal Vaccines Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Livestock Animal Vaccines Sales Volume by Type
    • 3.3.1 Global Livestock Animal Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Livestock Animal Vaccines Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Livestock Animal Vaccines Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Livestock Animal Vaccines Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Pig
    • 4.1.2 Cattle
    • 4.1.3 Poultry
    • 4.1.4 Others
  • 4.2 Global Livestock Animal Vaccines Sales Value by Application
    • 4.2.1 Global Livestock Animal Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Livestock Animal Vaccines Sales Value, by Application (2020-2031)
    • 4.2.3 Global Livestock Animal Vaccines Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Livestock Animal Vaccines Sales Volume by Application
    • 4.3.1 Global Livestock Animal Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Livestock Animal Vaccines Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Livestock Animal Vaccines Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Livestock Animal Vaccines Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Livestock Animal Vaccines Sales Value by Region
    • 5.1.1 Global Livestock Animal Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Livestock Animal Vaccines Sales Value by Region (2020-2025)
    • 5.1.3 Global Livestock Animal Vaccines Sales Value by Region (2026-2031)
    • 5.1.4 Global Livestock Animal Vaccines Sales Value by Region (%), (2020-2031)
  • 5.2 Global Livestock Animal Vaccines Sales Volume by Region
    • 5.2.1 Global Livestock Animal Vaccines Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Livestock Animal Vaccines Sales Volume by Region (2020-2025)
    • 5.2.3 Global Livestock Animal Vaccines Sales Volume by Region (2026-2031)
    • 5.2.4 Global Livestock Animal Vaccines Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Livestock Animal Vaccines Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.4.2 North America Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.5.2 Europe Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Livestock Animal Vaccines Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.7.2 South America Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Livestock Animal Vaccines Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Livestock Animal Vaccines Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Livestock Animal Vaccines Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.3.2 United States Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.4.2 Europe Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.5.2 China Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.6.2 Japan Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.7.2 South Korea Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.9.2 India Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Merck
    • 7.1.1 Merck Company Information
    • 7.1.2 Merck Introduction and Business Overview
    • 7.1.3 Merck Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Merck Livestock Animal Vaccines Product Offerings
    • 7.1.5 Merck Recent Development
  • 7.2 Boehringer Ingelheim
    • 7.2.1 Boehringer Ingelheim Company Information
    • 7.2.2 Boehringer Ingelheim Introduction and Business Overview
    • 7.2.3 Boehringer Ingelheim Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Boehringer Ingelheim Livestock Animal Vaccines Product Offerings
    • 7.2.5 Boehringer Ingelheim Recent Development
  • 7.3 Zoetis
    • 7.3.1 Zoetis Company Information
    • 7.3.2 Zoetis Introduction and Business Overview
    • 7.3.3 Zoetis Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Zoetis Livestock Animal Vaccines Product Offerings
    • 7.3.5 Zoetis Recent Development
  • 7.4 Ceva
    • 7.4.1 Ceva Company Information
    • 7.4.2 Ceva Introduction and Business Overview
    • 7.4.3 Ceva Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Ceva Livestock Animal Vaccines Product Offerings
    • 7.4.5 Ceva Recent Development
  • 7.5 Elanco
    • 7.5.1 Elanco Company Information
    • 7.5.2 Elanco Introduction and Business Overview
    • 7.5.3 Elanco Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Elanco Livestock Animal Vaccines Product Offerings
    • 7.5.5 Elanco Recent Development
  • 7.6 CAHIC
    • 7.6.1 CAHIC Company Information
    • 7.6.2 CAHIC Introduction and Business Overview
    • 7.6.3 CAHIC Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 CAHIC Livestock Animal Vaccines Product Offerings
    • 7.6.5 CAHIC Recent Development
  • 7.7 Jinyu Bio-Technology
    • 7.7.1 Jinyu Bio-Technology Company Information
    • 7.7.2 Jinyu Bio-Technology Introduction and Business Overview
    • 7.7.3 Jinyu Bio-Technology Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Jinyu Bio-Technology Livestock Animal Vaccines Product Offerings
    • 7.7.5 Jinyu Bio-Technology Recent Development
  • 7.8 HVRI
    • 7.8.1 HVRI Company Information
    • 7.8.2 HVRI Introduction and Business Overview
    • 7.8.3 HVRI Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 HVRI Livestock Animal Vaccines Product Offerings
    • 7.8.5 HVRI Recent Development
  • 7.9 Ringpu Biology
    • 7.9.1 Ringpu Biology Company Information
    • 7.9.2 Ringpu Biology Introduction and Business Overview
    • 7.9.3 Ringpu Biology Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Ringpu Biology Livestock Animal Vaccines Product Offerings
    • 7.9.5 Ringpu Biology Recent Development
  • 7.10 Yebio
    • 7.10.1 Yebio Company Information
    • 7.10.2 Yebio Introduction and Business Overview
    • 7.10.3 Yebio Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Yebio Livestock Animal Vaccines Product Offerings
    • 7.10.5 Yebio Recent Development
  • 7.11 DHN
    • 7.11.1 DHN Company Information
    • 7.11.2 DHN Introduction and Business Overview
    • 7.11.3 DHN Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 DHN Livestock Animal Vaccines Product Offerings
    • 7.11.5 DHN Recent Development
  • 7.12 Kyoto Biken Laboratories
    • 7.12.1 Kyoto Biken Laboratories Company Information
    • 7.12.2 Kyoto Biken Laboratories Introduction and Business Overview
    • 7.12.3 Kyoto Biken Laboratories Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Kyoto Biken Laboratories Livestock Animal Vaccines Product Offerings
    • 7.12.5 Kyoto Biken Laboratories Recent Development
  • 7.13 WINSUN
    • 7.13.1 WINSUN Company Information
    • 7.13.2 WINSUN Introduction and Business Overview
    • 7.13.3 WINSUN Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 WINSUN Livestock Animal Vaccines Product Offerings
    • 7.13.5 WINSUN Recent Development
  • 7.14 FATRO
    • 7.14.1 FATRO Company Information
    • 7.14.2 FATRO Introduction and Business Overview
    • 7.14.3 FATRO Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 FATRO Livestock Animal Vaccines Product Offerings
    • 7.14.5 FATRO Recent Development
  • 7.15 CAVAC
    • 7.15.1 CAVAC Company Information
    • 7.15.2 CAVAC Introduction and Business Overview
    • 7.15.3 CAVAC Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 CAVAC Livestock Animal Vaccines Product Offerings
    • 7.15.5 CAVAC Recent Development
  • 7.16 MEVAC
    • 7.16.1 MEVAC Company Information
    • 7.16.2 MEVAC Introduction and Business Overview
    • 7.16.3 MEVAC Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 MEVAC Livestock Animal Vaccines Product Offerings
    • 7.16.5 MEVAC Recent Development
  • 7.17 Biovac
    • 7.17.1 Biovac Company Information
    • 7.17.2 Biovac Introduction and Business Overview
    • 7.17.3 Biovac Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Biovac Livestock Animal Vaccines Product Offerings
    • 7.17.5 Biovac Recent Development
  • 7.18 Cavet bio
    • 7.18.1 Cavet bio Company Information
    • 7.18.2 Cavet bio Introduction and Business Overview
    • 7.18.3 Cavet bio Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Cavet bio Livestock Animal Vaccines Product Offerings
    • 7.18.5 Cavet bio Recent Development
  • 7.19 Vaksindo
    • 7.19.1 Vaksindo Company Information
    • 7.19.2 Vaksindo Introduction and Business Overview
    • 7.19.3 Vaksindo Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Vaksindo Livestock Animal Vaccines Product Offerings
    • 7.19.5 Vaksindo Recent Development
  • 7.20 Bio-Labs
    • 7.20.1 Bio-Labs Company Information
    • 7.20.2 Bio-Labs Introduction and Business Overview
    • 7.20.3 Bio-Labs Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Bio-Labs Livestock Animal Vaccines Product Offerings
    • 7.20.5 Bio-Labs Recent Development

8 Industry Chain Analysis

  • 8.1 Livestock Animal Vaccines Industrial Chain
  • 8.2 Livestock Animal Vaccines Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Livestock Animal Vaccines Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Livestock Animal Vaccines Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Livestock Animal Vaccines Market Trends
  • Table 2. Livestock Animal Vaccines Market Drivers & Opportunity
  • Table 3. Livestock Animal Vaccines Market Challenges
  • Table 4. Livestock Animal Vaccines Market Restraints
  • Table 5. Global Livestock Animal Vaccines Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Livestock Animal Vaccines Revenue Market Share by Company (2020-2025)
  • Table 7. Global Livestock Animal Vaccines Sales Volume by Company (2020-2025) & (M Dose)
  • Table 8. Global Livestock Animal Vaccines Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Livestock Animal Vaccines Price by Company (2020-2025) & (US$/Dose)
  • Table 10. Key Manufacturers Livestock Animal Vaccines Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Livestock Animal Vaccines Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Livestock Animal Vaccines
  • Table 13. Global Livestock Animal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Livestock Animal Vaccines as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Livestock Animal Vaccines Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Livestock Animal Vaccines Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Livestock Animal Vaccines Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Livestock Animal Vaccines Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Livestock Animal Vaccines Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Livestock Animal Vaccines Sales Volume by Type: 2020 VS 2024 VS 2031 (M Dose)
  • Table 22. Global Livestock Animal Vaccines Sales Volume by Type (2020-2025) & (M Dose)
  • Table 23. Global Livestock Animal Vaccines Sales Volume by Type (2026-2031) & (M Dose)
  • Table 24. Global Livestock Animal Vaccines Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Livestock Animal Vaccines Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Livestock Animal Vaccines Price by Type (2020-2025) & (US$/Dose)
  • Table 27. Global Livestock Animal Vaccines Price by Type (2026-2031) & (US$/Dose)
  • Table 28. Global Livestock Animal Vaccines Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Livestock Animal Vaccines Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Livestock Animal Vaccines Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Livestock Animal Vaccines Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Livestock Animal Vaccines Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Livestock Animal Vaccines Sales Volume by Application: 2020 VS 2024 VS 2031 (M Dose)
  • Table 34. Global Livestock Animal Vaccines Sales Volume by Application (2020-2025) & (M Dose)
  • Table 35. Global Livestock Animal Vaccines Sales Volume by Application (2026-2031) & (M Dose)
  • Table 36. Global Livestock Animal Vaccines Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Livestock Animal Vaccines Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Livestock Animal Vaccines Price by Application (2020-2025) & (US$/Dose)
  • Table 39. Global Livestock Animal Vaccines Price by Application (2026-2031) & (US$/Dose)
  • Table 40. Global Livestock Animal Vaccines Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Livestock Animal Vaccines Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Livestock Animal Vaccines Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Livestock Animal Vaccines Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Livestock Animal Vaccines Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Livestock Animal Vaccines Sales Volume by Region (M Dose): 2020 VS 2024 VS 2031
  • Table 46. Global Livestock Animal Vaccines Sales Volume by Region (2020-2025) & (M Dose)
  • Table 47. Global Livestock Animal Vaccines Sales Volume by Region (2026-2031) & (M Dose)
  • Table 48. Global Livestock Animal Vaccines Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Livestock Animal Vaccines Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Livestock Animal Vaccines Average Price by Region (2020-2025) & (US$/Dose)
  • Table 51. Global Livestock Animal Vaccines Average Price by Region (2026-2031) & (US$/Dose)
  • Table 52. Key Countries/Regions Livestock Animal Vaccines Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Livestock Animal Vaccines Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Livestock Animal Vaccines Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Livestock Animal Vaccines Sales Volume, (2020-2025) & (M Dose)
  • Table 56. Key Countries/Regions Livestock Animal Vaccines Sales Volume, (2026-2031) & (M Dose)
  • Table 57. Merck Company Information
  • Table 58. Merck Introduction and Business Overview
  • Table 59. Merck Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 60. Merck Livestock Animal Vaccines Product Offerings
  • Table 61. Merck Recent Development
  • Table 62. Boehringer Ingelheim Company Information
  • Table 63. Boehringer Ingelheim Introduction and Business Overview
  • Table 64. Boehringer Ingelheim Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 65. Boehringer Ingelheim Livestock Animal Vaccines Product Offerings
  • Table 66. Boehringer Ingelheim Recent Development
  • Table 67. Zoetis Company Information
  • Table 68. Zoetis Introduction and Business Overview
  • Table 69. Zoetis Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 70. Zoetis Livestock Animal Vaccines Product Offerings
  • Table 71. Zoetis Recent Development
  • Table 72. Ceva Company Information
  • Table 73. Ceva Introduction and Business Overview
  • Table 74. Ceva Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 75. Ceva Livestock Animal Vaccines Product Offerings
  • Table 76. Ceva Recent Development
  • Table 77. Elanco Company Information
  • Table 78. Elanco Introduction and Business Overview
  • Table 79. Elanco Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 80. Elanco Livestock Animal Vaccines Product Offerings
  • Table 81. Elanco Recent Development
  • Table 82. CAHIC Company Information
  • Table 83. CAHIC Introduction and Business Overview
  • Table 84. CAHIC Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 85. CAHIC Livestock Animal Vaccines Product Offerings
  • Table 86. CAHIC Recent Development
  • Table 87. Jinyu Bio-Technology Company Information
  • Table 88. Jinyu Bio-Technology Introduction and Business Overview
  • Table 89. Jinyu Bio-Technology Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 90. Jinyu Bio-Technology Livestock Animal Vaccines Product Offerings
  • Table 91. Jinyu Bio-Technology Recent Development
  • Table 92. HVRI Company Information
  • Table 93. HVRI Introduction and Business Overview
  • Table 94. HVRI Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 95. HVRI Livestock Animal Vaccines Product Offerings
  • Table 96. HVRI Recent Development
  • Table 97. Ringpu Biology Company Information
  • Table 98. Ringpu Biology Introduction and Business Overview
  • Table 99. Ringpu Biology Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 100. Ringpu Biology Livestock Animal Vaccines Product Offerings
  • Table 101. Ringpu Biology Recent Development
  • Table 102. Yebio Company Information
  • Table 103. Yebio Introduction and Business Overview
  • Table 104. Yebio Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 105. Yebio Livestock Animal Vaccines Product Offerings
  • Table 106. Yebio Recent Development
  • Table 107. DHN Company Information
  • Table 108. DHN Introduction and Business Overview
  • Table 109. DHN Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 110. DHN Livestock Animal Vaccines Product Offerings
  • Table 111. DHN Recent Development
  • Table 112. Kyoto Biken Laboratories Company Information
  • Table 113. Kyoto Biken Laboratories Introduction and Business Overview
  • Table 114. Kyoto Biken Laboratories Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 115. Kyoto Biken Laboratories Livestock Animal Vaccines Product Offerings
  • Table 116. Kyoto Biken Laboratories Recent Development
  • Table 117. WINSUN Company Information
  • Table 118. WINSUN Introduction and Business Overview
  • Table 119. WINSUN Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 120. WINSUN Livestock Animal Vaccines Product Offerings
  • Table 121. WINSUN Recent Development
  • Table 122. FATRO Company Information
  • Table 123. FATRO Introduction and Business Overview
  • Table 124. FATRO Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 125. FATRO Livestock Animal Vaccines Product Offerings
  • Table 126. FATRO Recent Development
  • Table 127. CAVAC Company Information
  • Table 128. CAVAC Introduction and Business Overview
  • Table 129. CAVAC Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 130. CAVAC Livestock Animal Vaccines Product Offerings
  • Table 131. CAVAC Recent Development
  • Table 132. MEVAC Company Information
  • Table 133. MEVAC Introduction and Business Overview
  • Table 134. MEVAC Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 135. MEVAC Livestock Animal Vaccines Product Offerings
  • Table 136. MEVAC Recent Development
  • Table 137. Biovac Company Information
  • Table 138. Biovac Introduction and Business Overview
  • Table 139. Biovac Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 140. Biovac Livestock Animal Vaccines Product Offerings
  • Table 141. Biovac Recent Development
  • Table 142. Cavet bio Company Information
  • Table 143. Cavet bio Introduction and Business Overview
  • Table 144. Cavet bio Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 145. Cavet bio Livestock Animal Vaccines Product Offerings
  • Table 146. Cavet bio Recent Development
  • Table 147. Vaksindo Company Information
  • Table 148. Vaksindo Introduction and Business Overview
  • Table 149. Vaksindo Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 150. Vaksindo Livestock Animal Vaccines Product Offerings
  • Table 151. Vaksindo Recent Development
  • Table 152. Bio-Labs Company Information
  • Table 153. Bio-Labs Introduction and Business Overview
  • Table 154. Bio-Labs Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 155. Bio-Labs Livestock Animal Vaccines Product Offerings
  • Table 156. Bio-Labs Recent Development
  • Table 157. Key Raw Materials Lists
  • Table 158. Raw Materials Key Suppliers Lists
  • Table 159. Livestock Animal Vaccines Downstream Customers
  • Table 160. Livestock Animal Vaccines Distributors List
  • Table 161. Research Programs/Design for This Report
  • Table 162. Key Data Information from Secondary Sources
  • Table 163. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Livestock Animal Vaccines Product Picture
  • Figure 2. Global Livestock Animal Vaccines Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Livestock Animal Vaccines Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Livestock Animal Vaccines Sales Volume (2020-2031) & (M Dose)
  • Figure 5. Global Livestock Animal Vaccines Sales Price (2020-2031) & (US$/Dose)
  • Figure 6. Livestock Animal Vaccines Report Years Considered
  • Figure 7. Global Livestock Animal Vaccines Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Livestock Animal Vaccines Players Sales Volume Ranking (2024) & (M Dose)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Livestock Animal Vaccines Revenue in 2024
  • Figure 10. Livestock Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Live Attenuated Vaccine Picture
  • Figure 12. Inactivated Vaccine Picture
  • Figure 13. Other Vaccines Picture
  • Figure 14. Global Livestock Animal Vaccines Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Livestock Animal Vaccines Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Livestock Animal Vaccines Sales Volume by Type (2020 VS 2024 VS 2031) & (M Dose)
  • Figure 17. Global Livestock Animal Vaccines Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Livestock Animal Vaccines Price by Type (2020-2031) & (US$/Dose)
  • Figure 19. Product Picture of Pig
  • Figure 20. Product Picture of Cattle
  • Figure 21. Product Picture of Poultry
  • Figure 22. Product Picture of Others
  • Figure 23. Global Livestock Animal Vaccines Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 24. Global Livestock Animal Vaccines Sales Value Market Share by Application, 2024 & 2031
  • Figure 25. Global Livestock Animal Vaccines Sales Volume by Application (2020 VS 2024 VS 2031) & (M Dose)
  • Figure 26. Global Livestock Animal Vaccines Sales Volume Market Share by Application, 2024 & 2031
  • Figure 27. Global Livestock Animal Vaccines Price by Application (2020-2031) & (US$/Dose)
  • Figure 28. North America Livestock Animal Vaccines Sales Value (2020-2031) & (US$ Million)
  • Figure 29. North America Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Europe Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Asia Pacific Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Asia Pacific Livestock Animal Vaccines Sales Value by Region (%), 2024 VS 2031
  • Figure 34. South America Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. South America Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Middle East & Africa Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Middle East & Africa Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • Figure 38. Key Countries/Regions Livestock Animal Vaccines Sales Value (%), (2020-2031)
  • Figure 39. Key Countries/Regions Livestock Animal Vaccines Sales Volume (%), (2020-2031)
  • Figure 40. United States Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. United States Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 42. United States Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Europe Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Europe Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Europe Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 46. China Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. China Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 48. China Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Japan Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. Japan Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 51. Japan Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 52. South Korea Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. South Korea Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 54. South Korea Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 55. Southeast Asia Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. Southeast Asia Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 57. Southeast Asia Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 58. India Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 59. India Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 60. India Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 61. Livestock Animal Vaccines Industrial Chain
  • Figure 62. Livestock Animal Vaccines Manufacturing Cost Structure
  • Figure 63. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed